Sign In
Buy CVS
$98.32
-0.84 (-0.85%)
At Close: Jun 18, 2026
CVS shares drop 4.2% on guidance downgrade
09:08am, Wednesday, 01'st Nov 2023
CVS Health Corp (NYSE:CVS) bobbed and weaved to put the best gloss on its third-quarter earnings update early on – only to see the stock flop 4.2% premarket. Okay, the good news was that the bottom-
CVS Health Profits Eclipse $2.2 Billion As Company Integrates New Provider Businesses
07:00am, Wednesday, 01'st Nov 2023
CVS Health reported third quarter net income of $2.2 billion thanks in part to contributions from its new healthcare services acquisitions.
CVS Earnings Top Estimates but Stock Drops as Outlook Slashed Again
06:54am, Wednesday, 01'st Nov 2023
CVS revises lower its guidance range for diluted GAAP earnings per share for the third straight quarter.
CVS Health's stock up after earnings beat, but company lowers full-year EPS guidance
06:39am, Wednesday, 01'st Nov 2023
CVS Health Corp.'s stock CVS was up 0.8% premarket Wednesday, after the drug store chain posted stronger-than-expected third-quarter earnings, shrugging off lower profit guidance for the full year. Th
CVS profit beats estimates on strong performance of pharmacy operations
06:36am, Wednesday, 01'st Nov 2023
CVS Health Corp beat Wall Street estimates for quarterly profit on Wednesday as strength in its drugstores and pharmacy benefit management business offset higher-than-expected medical costs at its ins
CVS results top expectations, lifted by strong health services revenue
06:31am, Wednesday, 01'st Nov 2023
The results come on the last day of a nationwide walkout by pharmacy staff from CVS, Walgreens and Rite Aid to protest what they call harsh working conditions.
Pharma Giant Prepares for Earnings Call
12:32pm, Tuesday, 31'st Oct 2023
Pharmaceutical concern CVS Health Corp (NYSE:CVS) will enter the earnings confessional before the open tomorrow.
FDA warns against use of two-dozen eye drop products sold at CVS, Rite Aid over risk of infection and vision loss
03:09pm, Monday, 30'th Oct 2023
The FDA is telling consumers to avoid two dozen eye drop products sold at major retailers including CVS and Rite Aid, because they could cause eye infections and potentially lead to vision loss.
CVS, Walgreens workers plan 3-day walkout
01:01pm, Monday, 30'th Oct 2023
Walgreens (WBA) and CVS Health (CVS) workers are the newest batch of health care workers to threaten strikes against employers. Yahoo Finance Health Reporter Anjalee Khemlani details the demands in th
CVS, Target and other eye-drop products pose risk of dangerous infections, FDA warns
12:10pm, Monday, 30'th Oct 2023
More than two dozen over-the-counter eye-drop products marketed under CVS Health Corp. CVS, +1.40%, Target Corp. TGT, +1.15%, Rite Aid Corp. RADCQ, +8.91% and other brands pose a risk of eye infection
Strike Alert 2023: Workers at CVS, Walgreens, Rite Aid Walk Out
11:53am, Monday, 30'th Oct 2023
Workers at pharmacy companies CVS (NYSE: CVS ), Walgreens (NASDAQ: WBA ) and RiteAid (OTCMKTS: RADCQ ) have staged a strike that has them walking out on the businesses for three days to highlight work
CVS, Walgreens Pharmacists Could Walk Off Job
05:21pm, Friday, 27'th Oct 2023
Thousands of pharmacists at CVS and Walgreens could go on strike in an effort to improve working conditions and staffing levels. Shane Jerominski is an independent pharmacist.
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
10:34am, Thursday, 26'th Oct 2023
CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
These 2 Retail and Wholesale Stocks Could Beat Earnings: Why They Should Be on Your Radar
10:34am, Wednesday, 25'th Oct 2023
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
CVS Health could see another earnings surprise in 3Q: analysts
04:36pm, Monday, 23'rd Oct 2023
CVS Health Corp (NYSE:CVS) will report its third quarter 2023 financial results on November 1, with analysts calling for earnings per share (EPS) of $2.13, reflecting a year-over-year increase of ju
